At the Virtual Great Debates & Updates in Hematologic Malignancies, Jonathon Cohen, MD, presented standard treatment regiments and novel agents for the treatment of MCL.
Dr Jabbour discusses his presentation from the virtual Great Debates and Updates in Hematologic Malignancies on the management of patients with Ph+ and Ph-like ALL.
At the virtual Great Debates & Updates in Hematologic Malignancies, Michael Mauro, MD, presented on practical approaches for monitoring patients with CML as per NCCN and ELN recommendations.
During the Great Debates & Updates in Hematologic Malignancies, Gail Roboz, MD, discussed how clinicians can lead patients with AML down the correct treatment path.
At the virtual Great Debates & Updates in Hematologic Malignancies, Jonathan Kaufman, MD, discussed the standard front-line approach for treating patients with MM ineligible for transplantation.
Joseph Mikhael, MD, talks about what attendees can expect from the myeloma session at this year's virtual Great Debates & Updates in Hematologic Malignancies.
Dr Jabbour will be presenting on the management of patients with Ph+ and Ph-like ALL and taking part in a debate on approaches for the treatment of patients with relapsed ALL.
Dr Roboz gives attendees a taste of what's to come at this year's virtual Great Debates & Updates in Hematologic Malignancies.
Stay in the know.
OncNet Newsletter